Compare IQV & CRDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IQV | CRDO |
|---|---|---|
| Founded | 1982 | 2008 |
| Country | United States | Cayman Islands |
| Employees | 93000 | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.6B | 32.2B |
| IPO Year | 2013 | 2022 |
| Metric | IQV | CRDO |
|---|---|---|
| Price | $168.96 | $212.59 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 14 |
| Target Price | ★ $227.13 | $179.62 |
| AVG Volume (30 Days) | 1.6M | ★ 5.2M |
| Earning Date | 05-05-2026 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 4.67 | ★ 261.11 |
| EPS | 1.61 | ★ 1.62 |
| Revenue | ★ $9,739,000,000.00 | $436,775,000.00 |
| Revenue This Year | $6.77 | $210.92 |
| Revenue Next Year | $5.89 | $57.22 |
| P/E Ratio | ★ $104.62 | $119.57 |
| Revenue Growth | 41.60 | ★ 126.34 |
| 52 Week Low | $137.33 | $59.21 |
| 52 Week High | $247.05 | $213.80 |
| Indicator | IQV | CRDO |
|---|---|---|
| Relative Strength Index (RSI) | 47.41 | 63.58 |
| Support Level | $159.08 | $129.63 |
| Resistance Level | $172.80 | N/A |
| Average True Range (ATR) | 7.14 | 17.11 |
| MACD | -0.19 | -1.11 |
| Stochastic Oscillator | 46.88 | 99.75 |
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its reserach and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.
Credo Technology Group Holding Ltd delivers high-speed solutions to break bandwidth barriers on every wired connection in the data infrastructure market. It provides secure, high-speed connectivity solutions that deliver improved power and cost efficiency as data rates and corresponding bandwidth requirements increase exponentially throughout the data infrastructure market. It has a geographic presence in Hong Kong, the United States, Mainland China, Taiwan, and the Rest of the World.